UC-MSC-Derived Secretome
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UC-MSC-Derived Secretome, covering 2026-01-13 to 2026-01-13. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II/III Randomized Double-Blind Multicenter Study Comparing UC-MSC-Derived Secretome and Sodium Hyaluronate in Patients With Knee Osteoarthritis [Phase 2, Phase 3]